Page last updated: 2024-11-02

oxophenylarsine and Burkitt Lymphoma

oxophenylarsine has been researched along with Burkitt Lymphoma in 2 studies

oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.

Burkitt Lymphoma: A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sun, XM1
Canda-Sánchez, A1
Manjeri, GR1
Cohen, GM1
Pinkoski, MJ1
Rozsnyay, Z1
Sarmay, G1
Gergely, J1

Other Studies

2 other studies available for oxophenylarsine and Burkitt Lymphoma

ArticleYear
Phenylarsine oxide interferes with the death inducing signaling complex and inhibits tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induced apoptosis.
    Experimental cell research, 2009, Aug-15, Volume: 315, Issue:14

    Topics: Apoptosis; Arsenicals; Burkitt Lymphoma; Caspase Inhibitors; Caspases; Cell Line, Tumor; Endocytosis

2009
Rapid desensitization of B-cell receptor by a dithiol-reactive protein tyrosine phosphatase inhibitor: uncoupling of membrane IgM from syk inhibits signals leading to Ca2+ mobilization.
    Immunology letters, 1995, Volume: 44, Issue:2-3

    Topics: Antigens, CD; Antigens, CD19; Antigens, Differentiation, B-Lymphocyte; Arsenicals; B-Lymphocytes; Bu

1995